We are live on ! Find out more
TOI icon

The Oncology Institute

49 hedge funds and large institutions have $205M invested in The Oncology Institute in 2020 Q4 according to their latest regulatory filings, with 16 funds opening new positions, 6 increasing their positions, 11 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed

220% more first-time investments, than exits

New positions opened: 16 | Existing positions closed: 5

154% more capital invested

Capital invested by funds: $80.8M → $205M (+$124M)

41.79% more ownership

Funds ownership: 40.75%82.55% (+42%)

29% more funds holding

Funds holding: 3849 (+11)

45% less repeat investments, than reductions

Existing positions increased: 6 | Existing positions reduced: 11

Holders
49
Holders Change
+11
Holders Change %
+28.95%
% of All Funds
0.87%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
16
Increased
6
Reduced
11
Closed
5
Calls
$656K
Puts
Net Calls
+$656K
Net Calls Change
-$82K
Name Holding Trade Value Shares
Change
Change in
Stake
CCA
26
Castle Creek Arbitrage
Colorado
$1.77M +$906K +88,000 +116%
OP
27
Omni Partners
United Kingdom
$1.76M +$1.68M +163,362 New
CL
28
CSS LLC
Illinois
$1.5M +$1.43M +138,683 New
DAM
29
Deltec Asset Management
New York
$1.08M
PSAMP
30
P. Schoenfeld Asset Management (PSAM)
New York
$1.08M
TCM
31
Tenor Capital Management
New York
$1.08M
PC
32
Periscope Capital
Ontario, Canada
$1.08M +$1.03M +100,000 New
LA
33
Linden Advisors
New York
$1.08M
Goldman Sachs
34
Goldman Sachs
New York
$810K +$772K +75,000 New
FTCM
35
First Trust Capital Management
Illinois
$744K
CC
36
Centiva Capital
New York
$605K +$61.8K +6,000 +12%
DCM
37
Dupont Capital Management
Delaware
$540K
JG
38
Jefferies Group
New York
$432K -$618K -60,000 -60%
BPIM
39
Brant Point Investment Management
New York
$273K +$260K +25,233 New
AA
40
AQR Arbitrage
Connecticut
$270K
MSU
41
Mizuho Securities USA
New York
$262K -$257K -25,000 -50%
CAPTRUST Financial Advisors
42
CAPTRUST Financial Advisors
North Carolina
$209K +$199K +19,348 New
SCM
43
Saba Capital Management
New York
$187K -$828K -80,443 -82%
Geode Capital Management
44
Geode Capital Management
Massachusetts
$113K -$408K -39,673 -79%
CWM
45
Centric Wealth Management
Illinois
$108K +$103K +10,000 New
Morgan Stanley
46
Morgan Stanley
New York
$11K +$9.73K +945 +1,260%
UBS Group
47
UBS Group
Switzerland
$5K -$10.7K -1,044 -68%
Royal Bank of Canada
48
Royal Bank of Canada
Ontario, Canada
$3K
FTCM
49
Fir Tree Capital Management
New York
-$2.59M -250,000 Closed
AGM
50
Alpine Global Management
New York
-$664K -64,081 Closed

TOI Hedge Fund Activity: Q4 2020 in Review

49 of the 5,651 institutional investors tracked by Wall St. Rank reported a position in The Oncology Institute (TOI) for Q4 2020, worth a combined $205M — up 154% from $80.8M a quarter earlier.

Buyers outnumbered sellers: 16 funds opened new TOI positions and 5 closed out — a net gain of 11 holders — while 6 added to existing stakes and 11 trimmed.

The largest buyer was Deerfield Management, opening a new position worth an estimated $56.2M. The largest seller was UBS O'Connor, cutting an estimated $3.05M.

  • 49 institutional investors held The Oncology Institute (TOI) as of Q4 2020, up from 38 in Q3 2020.
  • Funds reported $205M of The Oncology Institute stock for Q4 2020, up 154% quarter-over-quarter.
  • 16 funds opened new The Oncology Institute positions in Q4 2020 and 5 closed out, a net change of +11 holders.
  • The largest The Oncology Institute buyer in Q4 2020 was Deerfield Management, an estimated $56.2M added.
  • The largest The Oncology Institute seller in Q4 2020 was UBS O'Connor, an estimated $3.05M sold.

Based on aggregated 13F filings for Q4 2020.